Status:
TERMINATED
A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)
Lead Sponsor:
Center for Human Reproduction
Collaborating Sponsors:
Foundation for Reproductive Medicine
Conditions:
Infertility
Decreased Ovarian Reserve
Eligibility:
FEMALE
40-45 years
Phase:
PHASE2
PHASE3
Brief Summary
Our long term goal is to elucidate the role of DHEA on follicular dynamics in the human ovary and to better understand the interaction of DHEA supplementation with other treatments for ovulation induc...
Detailed Description
Specific Aims: The ability of women to respond to ovulation inducing medications also called ovarian reserve, declines with age. (Navot, Bergh et al. 1991; Scott, Leonardi et al. 1993; Toner and Floo...
Eligibility Criteria
Inclusion
- Women over the age of 40 and less than 45 years old presenting for IVF treatment.
- Willingness to sign informed consent for study randomization.
- Willingness to participate in 2 months pre-IVF treatment.
Exclusion
- Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia.
- Family history of significant genetic disease, or factor V Leiden thrombophilia.
- Inability to present for monitoring visits.
- Inability to follow medication instruction.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00419913
Start Date
January 1 2007
End Date
January 1 2008
Last Update
April 2 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Human Reproduction
New York, New York, United States, 10021
2
Institute fur Reproduktionsmedzin und Endokrinologie
Bregenz, Austria